Differential Associations of GAD Antibodies (GADA) and C-Peptide With Insulin Initiation, Glycemic Responses, and Severe Hypoglycemia in Patients Diagnosed With Type 2 Diabetes
Diabetes Care · 2023
DOI: 10.2337/dc22-2301 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, 2023. Verfasst von Baoqi Fan und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Hypoglycemia. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: The Hong Kong Government Health and Medical Research Fund, Research Grants Council Reseach Impact Fund.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE We examined the associations of GAD antibodies (GADA) and C-peptide (CP) with insulin initiation, glycemic responses, and severe hypoglycemia in type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS In 5,230 Chinese patients (47.6% men) with T2D (mean ± SD age: 56.5 ± 13.9 years; median diabetes duration: 6 [interquartile range 1, 12] years), enrolled consecutively in 1996–2012 and prospectively observed until 2019, we retrospectively measured fasting CP and GADA in stored serum and examined their associations with aforementioned outcomes. RESULTS At baseline, 28.6% (n = 1,494) had low CP (<200 pmol/L) and 4.9% (n = 257) had positive GADA (GADA+). In the low-CP group, 8.0% had GADA+, and, in the GADA+ group, 46.3% had low CP. The GADA+ group had an adjusted hazard ratio (aHR) of 1.46 (95% CI 1.15–1.84, P = 0.002) for insulin initiation versus the GADA− group, while the low-CP group had an aHR of 0.88 (0.77–1.00, P = 0.051) versus the high-CP group. Following insulin initiation, the GADA+ plus low-CP group had the largest decrements in HbA1c (−1.9% at month 6; −1.5% at month 12 vs. −1% in the other three groups). The aHR of severe hypoglycemia was 1.29 (95% CI 1.10–1.52, P = 0.002) in the low-CP group and 1.38 (95% CI 1.04–1.83, P = 0.024) in the GADA+ group. CONCLUSIONS There is considerable heterogeneity in autoimmunity and β-cell dysfunction in T2D with GADA+ and high CP associated with early insulin initiation, while GADA+ and low CP, increased the risk of severe hypoglycemia. Extended phenotyping is warranted to increase the precision of classification and treatment in T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.
- Li Ka Shing Institute of Health Sciences, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong.
- Jockey Club School of Public Health and Family Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.
- Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong.
ORCID-Profile: Aimin Yang, Claudia H T Tam, Alice P S Kong, Ronald C W Ma, Andrea O Y Luk, Juliana C N Chan
Förderung
- The Hong Kong Government Health and Medical Research Fund
- Research Grants Council Reseach Impact Fund
Zitieren
APA
Fan, B., Lim, C. K. P., Poon, E. W. M., Lau, E. S. H., Wu, H., Yang, A., Shi, M., Tam, C. H. T., Wong, S. Y. S., Lee, E. K., Wang, M. H. T., Chu, N. H. S., Ozaki, R., Kong, A. P. S., Chow, E., Ma, R. C. W., Luk, A. O. Y., & Chan, J. C. N. (2023). Differential Associations of GAD Antibodies (GADA) and C-Peptide With Insulin Initiation, Glycemic Responses, and Severe Hypoglycemia in Patients Diagnosed With Type 2 Diabetes. Diabetes Care. https://doi.org/10.2337/dc22-2301
Vancouver
Fan B, Lim CKP, Poon EWM, Lau ESH, Wu H, Yang A, et al. Differential Associations of GAD Antibodies (GADA) and C-Peptide With Insulin Initiation, Glycemic Responses, and Severe Hypoglycemia in Patients Diagnosed With Type 2 Diabetes. Diabetes Care. 2023. doi:10.2337/dc22-2301
BibTeX
@article{Fan2023,
author = {Fan, Baoqi and Lim, Cadmon K P and Poon, Emily W M and Lau, Eric S H and Wu, Hongjiang and Yang, Aimin and Shi, Mai and Tam, Claudia H T and Wong, Samuel Y S and Lee, Eric Kam-Pui and Wang, Maggie H T and Chu, Natural H S and Ozaki, Risa and Kong, Alice P S and Chow, Elaine and Ma, Ronald C W and Luk, Andrea O Y and Chan, Juliana C N},
title = {Differential Associations of GAD Antibodies (GADA) and C-Peptide With Insulin Initiation, Glycemic Responses, and Severe Hypoglycemia in Patients Diagnosed With Type 2 Diabetes},
journal = {Diabetes Care},
year = {2023},
doi = {10.2337/dc22-2301}
}
EUVIMED